Article Details
Retrieved on: 2022-12-05 23:32:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Australia-based, Immutep, this week announced a further extension to its immuno-oncology clinical pipeline.
Article found on: www.biopharma-reporter.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here